Why the study?
Does treatment with nitric oxide or cell adhesion molecule blockers prevent reperfusion injury in ischaemic vasculature?
Population
Ischaemic vasculature (coronary and mesenteric microcirculation) undergoing reperfusion
Design
Review
Authors
Loading...
Hypothesis-generating for pre-reperfusion NO or CAM blockade; clinical trials needed before any practice change.
Does treatment with nitric oxide or cell adhesion molecule blockers prevent reperfusion injury in ischaemic vasculature?
Nitric oxide supplementation or cell adhesion molecule blockade prior to reperfusion represents a promising approach to attenuate ischaemia-reperfusion injury and cardiac necrosis.
Lefer et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: